These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Is there any survival advantage of obesity in Southern European haemodialysis patients? Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli D. Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686 [Abstract] [Full Text] [Related]
10. Body mass index and enrollment on the renal transplant waiting list in the United States. Abbott KC, Glanton CW, Agodoa LY. J Nephrol; 2003 Sep; 16(1):40-8. PubMed ID: 12649534 [Abstract] [Full Text] [Related]
12. Survival benefit after liver transplantation: a single European center experience. Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD. Transplantation; 2009 Sep 27; 88(6):826-34. PubMed ID: 19920783 [Abstract] [Full Text] [Related]
13. Greater travel time to a liver transplant center does not adversely affect clinical outcomes. Firozvi AA, Lee CH, Hayashi PH. Liver Transpl; 2008 Jan 27; 14(1):18-24. PubMed ID: 18161800 [Abstract] [Full Text] [Related]
18. Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation. Thuluvath PJ. Liver Transpl; 2007 Dec 27; 13(12):1627-9. PubMed ID: 18044753 [No Abstract] [Full Text] [Related]
19. Morbid obesity is not a contraindication to kidney transplantation. Marks WH, Florence LS, Chapman PH, Precht AF, Perkinson DT. Am J Surg; 2004 May 27; 187(5):635-8. PubMed ID: 15135681 [Abstract] [Full Text] [Related]
20. Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models. Durand F, Belghiti J, Troisi R, Boillot O, Gadano A, Francoz C, de Hemptinne B, Mallet A, Valla D, Golmard JL. Liver Transpl; 2006 Feb 27; 12(2):231-9. PubMed ID: 16447208 [Abstract] [Full Text] [Related] Page: [Next] [New Search]